ghk-cu injection site recommendations subcutaneous Subcutaneous Injection Sites and Instructions for Safe Self-Administration ghk-cu injectable dosage subcutaneous ghk-cu
Description
The overall discontinuation rate due to adverse events was approximately 10%, which compares favorably to most compounds in this class

I do not share this information publicly

All research cited on this page is from preclinical animal studies
Vitamin B-12 deficiency symptoms may include: strange sensations, numbness, or tingling in the hands, legs, or feet difficulty walking (staggering, balance problems) anaemia a swollen, inflamed tongue difficulty thinking and reasoning (cognitive difficulties), or memory loss weakness fatigue While an experienced physician may notice the symptoms and be able to detect a vitamin B-12 deficiency with a good interview and physical exam, a blood test is needed to confirm the condition
Meta-analysis of GHK-Cu for skin aging

As a research compound, 5-Amino-1MQ has been studied in cellular biology and biochemical research literature examining NNMT (nicotinamide N-methyltransferase) enzyme inhibition, cellular nicotinamide metabolism, and methylation pathway research
